Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CAEP
Cantor Equity Partners III
$10.60
-1.4%
$0.00
$10.30
$11.09
$324.15MN/A361,173 shs42,318 shs
NXQ
Nuveen Select Tax-Free Income Portfolio 2
$15.04
$15.27
$14.95
$17.18
$266.42M0.1425,365 shs38,459 shs
Oaktree Acquisition Corp. III Life Sciences stock logo
OACC
Oaktree Acquisition Corp. III Life Sciences
$10.44
+0.1%
$10.48
$9.95
$10.85
$234.07MN/A25,318 shs2,004 shs
SVCC
Stellar V Capital
$10.24
$0.00
$9.95
$10.31
$221.29MN/A50,915 shs806 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CAEP
Cantor Equity Partners III
-0.19%+2.28%+1,074,999,900.00%+1,074,999,900.00%+1,074,999,900.00%
NXQ
Nuveen Select Tax-Free Income Portfolio 2
0.00%0.00%0.00%0.00%0.00%
Oaktree Acquisition Corp. III Life Sciences stock logo
OACC
Oaktree Acquisition Corp. III Life Sciences
+0.10%0.00%-1.42%+3.67%+1,043,999,900.00%
SVCC
Stellar V Capital
+0.10%+0.10%+1,023,999,900.00%+1,023,999,900.00%+1,023,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CAEP
Cantor Equity Partners III
N/AN/AN/AN/AN/AN/AN/AN/A
NXQ
Nuveen Select Tax-Free Income Portfolio 2
N/AN/AN/AN/AN/AN/AN/AN/A
Oaktree Acquisition Corp. III Life Sciences stock logo
OACC
Oaktree Acquisition Corp. III Life Sciences
N/AN/AN/AN/AN/AN/AN/AN/A
SVCC
Stellar V Capital
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CAEP
Cantor Equity Partners III
0.00
N/AN/AN/A
NXQ
Nuveen Select Tax-Free Income Portfolio 2
0.00
N/AN/AN/A
Oaktree Acquisition Corp. III Life Sciences stock logo
OACC
Oaktree Acquisition Corp. III Life Sciences
0.00
N/AN/AN/A
SVCC
Stellar V Capital
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CAEP
Cantor Equity Partners III
N/AN/AN/AN/AN/AN/A
NXQ
Nuveen Select Tax-Free Income Portfolio 2
N/AN/AN/AN/AN/AN/A
Oaktree Acquisition Corp. III Life Sciences stock logo
OACC
Oaktree Acquisition Corp. III Life Sciences
N/AN/AN/AN/AN/AN/A
SVCC
Stellar V Capital
N/AN/AN/AN/A($0.01) per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CAEP
Cantor Equity Partners III
N/AN/A0.00N/AN/AN/AN/AN/A
NXQ
Nuveen Select Tax-Free Income Portfolio 2
N/AN/A0.00N/AN/AN/AN/AN/A
Oaktree Acquisition Corp. III Life Sciences stock logo
OACC
Oaktree Acquisition Corp. III Life Sciences
N/AN/A0.00N/AN/AN/AN/AN/A
SVCC
Stellar V Capital
-$160KN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CAEP
Cantor Equity Partners III
N/AN/AN/AN/AN/A
NXQ
Nuveen Select Tax-Free Income Portfolio 2
$0.563.72%N/AN/AN/A
Oaktree Acquisition Corp. III Life Sciences stock logo
OACC
Oaktree Acquisition Corp. III Life Sciences
N/AN/AN/AN/AN/A
SVCC
Stellar V Capital
N/AN/AN/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
CAEP
Cantor Equity Partners III
230.58 millionN/AN/A
NXQ
Nuveen Select Tax-Free Income Portfolio 2
N/A17.71 million17.54 millionNot Optionable
Oaktree Acquisition Corp. III Life Sciences stock logo
OACC
Oaktree Acquisition Corp. III Life Sciences
N/A22.42 millionN/AN/A
SVCC
Stellar V Capital
321.61 millionN/AN/A

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cantor Equity Partners III NASDAQ:CAEP

$10.60 -0.15 (-1.40%)
As of 03:31 PM Eastern

We are a blank check company incorporated on November 11, 2020 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any discussions, directly or indirectly, with any business combination target regarding an initial business combination with our company. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region, although we expect to focus on a target in an industry where we believe our management team’s and our affiliates’ expertise will provide us with a competitive advantage, including the financial services, digital assets, healthcare, real estate services, technology and software industries. Further, our efforts to identify a prospective target business will not be limited to any characteristics, although we expect to favor potential target companies with certain characteristics which include, but are not limited to, positive long term growth prospects, competitive advantages, consolidation opportunities, recurring revenue or the potential for recurring revenue, opportunities for operational improvement and attractive margins or the potential for attractive margins. Our executive offices are located New York, New York.

Nuveen Select Tax-Free Income Portfolio 2 NYSE:NXQ

Nuveen Select Tax-Free Income Portfolio 2 is a closed-end investment fund/investment trust. Its investment objective is current income exempt from regular federal income tax, consistent with preservation of capital. The company was founded on May 21, 1992 and is headquartered in Chicago, IL.

Oaktree Acquisition Corp. III Life Sciences stock logo

Oaktree Acquisition Corp. III Life Sciences NASDAQ:OACC

$10.44 +0.01 (+0.10%)
As of 07/21/2025 04:00 PM Eastern

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.

Stellar V Capital NASDAQ:SVCC

$10.24 0.00 (0.00%)
As of 02:41 PM Eastern

We are a blank check company incorporated on July 12, 2024 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We have not selected any specific business combination target, and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. We may pursue an initial business combination target in any business or industry or at any stage of its corporate evolution. Our primary focus, however, will be in completing a business combination with an established business of scale poised for continued growth, led by a highly regarded management team. Our management team has an extensive track record of acquiring attractive assets at disciplined valuations, investing in growth while fostering financial discipline and improving business results. Our executive offices are located at 230 Park Avenue, Suite 1540, New York, NY.